HBAN vs LFCR · P/E 13, rev $1.56B vs rev $75.5M
Huntington Bancshares Incorporated (HBAN) versus Lifecore Biomedical Inc. (LFCR) — a side-by-side from cached financials, not a winner call.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Lifecore Biomedical Inc. (LFCR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Latest reported LFCR revenue for 2025-12-31 was $75.5M. Net income was -$18.0M. Revenue was up 771.6% from 2025-06-30 to 2025-12-31. LFCR currently screens at market cap $207.1M.
HBAN currently screens at market cap $25.55B and trailing P/E 13.5. LFCR currently screens at market cap $207.1M.
Not investment advice. Open the HBAN and LFCR stock pages for the full models.
Not investment advice.